Cargando…
Reply to: “Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does Not Deserve Its Bad Reputation”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349317/ https://www.ncbi.nlm.nih.gov/pubmed/33638041 http://dx.doi.org/10.1245/s10434-021-09743-z |
| _version_ | 1783735543942610944 |
|---|---|
| author | Horvath, Philipp Yurttas, Can |
| author_facet | Horvath, Philipp Yurttas, Can |
| author_sort | Horvath, Philipp |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8349317 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83493172021-08-20 Reply to: “Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does Not Deserve Its Bad Reputation” Horvath, Philipp Yurttas, Can Ann Surg Oncol Peritoneal Surface Malignancy Springer International Publishing 2021-02-26 2021 /pmc/articles/PMC8349317/ /pubmed/33638041 http://dx.doi.org/10.1245/s10434-021-09743-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Peritoneal Surface Malignancy Horvath, Philipp Yurttas, Can Reply to: “Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does Not Deserve Its Bad Reputation” |
| title | Reply to: “Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does Not Deserve Its Bad Reputation” |
| title_full | Reply to: “Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does Not Deserve Its Bad Reputation” |
| title_fullStr | Reply to: “Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does Not Deserve Its Bad Reputation” |
| title_full_unstemmed | Reply to: “Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does Not Deserve Its Bad Reputation” |
| title_short | Reply to: “Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does Not Deserve Its Bad Reputation” |
| title_sort | reply to: “cytoreductive surgery (crs) and hyperthermic intraperitoneal chemotherapy (hipec) definitively does not deserve its bad reputation” |
| topic | Peritoneal Surface Malignancy |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349317/ https://www.ncbi.nlm.nih.gov/pubmed/33638041 http://dx.doi.org/10.1245/s10434-021-09743-z |
| work_keys_str_mv | AT horvathphilipp replytocytoreductivesurgerycrsandhyperthermicintraperitonealchemotherapyhipecdefinitivelydoesnotdeserveitsbadreputation AT yurttascan replytocytoreductivesurgerycrsandhyperthermicintraperitonealchemotherapyhipecdefinitivelydoesnotdeserveitsbadreputation |